Lab Result Explanation

Overview

Provide comprehensive, clinically contextualized explanations of laboratory results including reference range interpretation, critical value identification, result trending over time, inter-test correlations, and diagnostic significance. This skill translates raw lab data into actionable clinical intelligence for healthcare providers, supporting diagnostic reasoning and treatment monitoring.

When to Use

Interpreting comprehensive metabolic panels, CBCs, or specialty lab panels
Explaining abnormal lab results in the context of patient conditions
Identifying critical values requiring immediate clinical action
Trending serial lab results to assess treatment response or disease progression
Correlating lab findings across multiple tests for diagnostic patterns
Generating lab summary reports for clinical handoffs

Required Inputs

| Input | Description | Format | |-------|-------------|--------| | Lab results | Test name, value, unit, reference range, specimen date | Array of lab objects | | Patient context | Age, sex, diagnoses, medications, renal/hepatic function | Structured object | | Historical labs | Prior results for trending (if available) | Array with dates | | Clinical question | Specific clinical context for interpretation | Free text | | Lab panel type | BMP, CMP, CBC, lipid, hepatic, thyroid, coagulation, etc. | String |

Methodology

Step 1: Result Classification

Classify each lab result:

Status Categories:

NORMAL: Within reference range, clinically insignificant
ABNORMAL-LOW: Below reference range
ABNORMAL-HIGH: Above reference range
CRITICAL-LOW: Below critical threshold, immediate action needed
CRITICAL-HIGH: Above critical threshold, immediate action needed
BORDERLINE: Near reference range boundary, clinical judgment needed

Reference Range Adjustments:

Age-adjusted ranges (e.g., creatinine in elderly, alkaline phosphatase in children)
Sex-adjusted ranges (e.g., hemoglobin, creatinine)
Pregnancy-adjusted ranges (e.g., TSH, alkaline phosphatase)
Medication-adjusted interpretation (e.g., INR on warfarin, TSH on levothyroxine)

Step 2: Critical Value Assessment

Identify results requiring immediate clinical notification:

| Test | Critical Low | Critical High | |------|-------------|---------------| | Potassium | Less than 2.5 mEq/L | Greater than 6.5 mEq/L | | Sodium | Less than 120 mEq/L | Greater than 160 mEq/L | | Glucose | Less than 40 mg/dL | Greater than 500 mg/dL | | Calcium (total) | Less than 6.0 mg/dL | Greater than 13.0 mg/dL | | Hemoglobin | Less than 7.0 g/dL | Greater than 20.0 g/dL | | Platelets | Less than 20K/uL | Greater than 1000K/uL | | INR | N/A | Greater than 5.0 | | Troponin | N/A | Above 99th percentile URL | | Lactate | N/A | Greater than 4.0 mmol/L | | WBC | Less than 1.0 K/uL | Greater than 30.0 K/uL |

Step 3: Clinical Contextualization

Map lab abnormalities to the patient's clinical context:

Diagnosis-Lab Correlation:

For each abnormal result, identify the most likely clinical explanation given active diagnoses
Flag unexpected abnormalities that do not fit the clinical picture (potential new findings)
Note medication effects on lab values (e.g., ACEi raising potassium, thiazides lowering sodium)
Identify lab patterns suggestive of specific conditions (e.g., elevated AST:ALT ratio greater than 2:1 suggesting alcoholic liver disease)

Inter-Test Correlations:

Anion gap with BMP results (metabolic acidosis workup)
BUN:Creatinine ratio (pre-renal vs. intrinsic renal)
Albumin correction for calcium (corrected Ca = measured Ca + 0.8 x (4.0 - albumin))
Calculated GFR from creatinine using CKD-EPI equation
Iron studies pattern recognition (iron deficiency vs. anemia of chronic disease vs. hemochromatosis)

Step 4: Trend Analysis

When historical labs are available, analyze trends:

Trending Parameters:

Direction: rising, falling, stable, fluctuating
Rate of change: rapid, gradual, expected for clinical context
Clinical significance: trending toward or away from critical thresholds
Treatment response: improving toward target or worsening despite treatment

Visual Trend Indicators:

Significant improvement (moving toward normal)
Stable abnormality (consistently out of range, chronic condition)
Worsening trend (moving away from normal)
Acute change (sudden significant shift from baseline)

Step 5: Explanation Generation

Produce the lab explanation tailored to the clinical audience:

For each abnormal result, provide:

What the test measures (brief)
What the result means clinically in this patient context
Most likely explanation given diagnoses and medications
Clinical significance and urgency level
Recommended follow-up testing or actions
If trending: direction and clinical implications of the trend

Output Specification

The output includes:

lab_panel_summary: panel_type, collection_date, overall_assessment (normal/mixed/significantly abnormal)

results (for each test): test_name, loinc_code, value, unit, reference_range, status (normal/abnormal-low/abnormal-high/critical), clinical_explanation, likely_etiology, related_diagnoses, medication_effects, recommended_action

critical_values: list of critical results requiring immediate notification with urgency_level and recommended_immediate_action

patterns_identified: pattern_name, involved_tests, clinical_significance, suggested_diagnosis_or_condition

trends (if historical data available): test_name, current_value, prior_values with dates, trend_direction, rate_of_change, clinical_interpretation

follow_up_recommendations: recommended_tests, rationale, timing, clinical_priority

Analysis Framework

Common Lab Panel Interpretive Patterns

| Pattern | Key Findings | Suggests | |---------|-------------|----------| | Pre-renal azotemia | BUN:Cr ratio greater than 20:1 | Dehydration, CHF, GI bleed | | Hepatocellular injury | AST/ALT elevated, Alk Phos normal | Hepatitis, drug toxicity, ischemia | | Cholestatic pattern | Alk Phos/GGT elevated, AST/ALT mildly elevated | Biliary obstruction, infiltrative disease | | DIC | Low platelets, elevated PT/PTT, low fibrinogen, elevated D-dimer | Disseminated intravascular coagulation | | Iron deficiency | Low iron, low ferritin, high TIBC, low transferrin sat | Iron deficiency anemia | | Tumor lysis | High K+, high phosphorus, high uric acid, low calcium | Cell lysis from chemotherapy | | SIADH | Low sodium, low serum osmolality, high urine osmolality | Inappropriate ADH secretion |

eGFR Staging (CKD-EPI 2021)

| Stage | eGFR (mL/min/1.73m2) | Description | |-------|----------------------|-------------| | G1 | 90 or greater | Normal or high | | G2 | 60-89 | Mildly decreased | | G3a | 45-59 | Mildly to moderately decreased | | G3b | 30-44 | Moderately to severely decreased | | G4 | 15-29 | Severely decreased | | G5 | Less than 15 | Kidney failure |

Examples

Input: CMP results for 68-year-old male with DM2, CHF, on lisinopril and furosemide. Na 131, K 5.8, BUN 45, Cr 2.1 (baseline 1.4), Glucose 210, CO2 18, Ca 8.2, Albumin 2.8.

Explanation (abbreviated):

CRITICAL: K+ 5.8 — hyperkalemia likely multifactorial (ACEi + worsening renal function). Immediate EKG needed. Consider holding lisinopril, kayexalate, recheck in 2 hours
Cr 2.1 (baseline 1.4): Acute kidney injury, likely pre-renal given CHF context. BUN:Cr ratio 21:1 supports pre-renal etiology. Assess volume status, consider holding/reducing furosemide
Na 131: Mild hyponatremia, likely hypervolemic in CHF context. Fluid restriction
CO2 18: Low, non-anion-gap metabolic acidosis, consistent with renal tubular acidosis in AKI
Ca corrected: 8.2 + 0.8 x (4.0 - 2.8) = 9.16 — corrected calcium is normal
Glucose 210: Uncontrolled, assess medication adherence, consider adjustment when renal function stabilizes

Guidelines

Always flag critical values prominently — these require immediate clinical action
Contextualize, do not just report — raw abnormal flags without context are not clinically useful
Account for medication effects — many abnormalities are expected consequences of treatment
Calculate derived values — anion gap, corrected calcium, eGFR, BUN:Cr ratio
Correlate across panels — patterns spanning multiple tests are more informative than isolated values

Validation Checklist

[ ] All critical values are prominently flagged with immediate action recommendations
[ ] Reference ranges are adjusted for patient demographics (age, sex, pregnancy)
[ ] Medication effects on lab values are identified and noted
[ ] Derived values (anion gap, corrected calcium, eGFR) are calculated where applicable
[ ] Inter-test correlations and diagnostic patterns are identified
[ ] Trend analysis is provided when historical data is available
[ ] Each abnormal result includes a clinical explanation specific to the patient context

HIPAA Compliance Notes

Lab results are PHI and must be handled with appropriate access controls
Lab explanation reports stored or transmitted must be encrypted (AES-256 at rest, TLS 1.2+ in transit)
De-identify lab data used for educational or research purposes
Critical value notifications must follow institutional notification policies and CLIA regulations
Patient access to their own lab results is required under HIPAA and 21st Century Cures Act information blocking rules